Company Overview
By using the body’s immune system, Anixa Biosciences is taking multiple approaches to fighting cancer—developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed.
Recent News
Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology
Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
Stock Overview
Symbol
ANIX
Exchange
Nasdaq
Market Cap
102.13m
Last Price
$3.06
52-Week Range
$2.331 - $5.4566
01/29/2026 05:28 PM EST
Investor Relations
Mike Catelani
President, COO & CFO
T: 408-708-9808